ethinyl estradiol has been researched along with ly2066948 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, HU; Clarke, CA; Cohen, IR; Coutant, DE; Dally, RD; Dodge, JA; Fong, KC; Frank, SA; Geiser, AG; Henck, JW; Hinklin, R; Hummel, CW; Jones, SA; Kohlman, DT; Lewis, G; McCann, DJ; Oldham, SW; Palkowitz, AD; Richardson, TI; Rudmann, DG; Shepherd, TA; Tian, H; Wallace, OB; Wang, M; Ying, BP | 1 |
| Adrian, MD; Bryant, HU; Cohen, IR; Dodge, JA; Donnelly, KB; Draper, MW; Geiser, AG; Henck, JW; Hummel, CW; McCann, DJ; Oldham, SW; Rudmann, DG; Sato, M; Shepherd, TA; Wallace, OB | 1 |
2 other study(ies) available for ethinyl estradiol and ly2066948
| Article | Year |
|---|---|
Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safety.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Drug Design; Estrogens; Female; Humans; Leiomyoma; Models, Chemical; Ovary; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Software; Structure-Activity Relationship | 2007 |
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation.
Topics: Animals; Bone and Bones; Cell Line, Tumor; Ethinyl Estradiol; Female; Humans; Kinetics; Naphthalenes; Ovariectomy; Ovulation Induction; Piperidines; Rats; Receptors, Estrogen; Sexual Maturation; Uterus | 2005 |